Literature DB >> 17933462

Peripheral neuropathy in patients with diabetes mellitus presenting as Bell's palsy.

Meral E Kiziltan1, M Ali Akalin, Rahsan Sahin, Derya Uluduz.   

Abstract

The aim of this study is to evaluate the peripheral nerves in diabetes mellitus with or without peripheral facial paralysis (PFP). A total of 49 diabetic patients with PFP within the last year (23 females, mean age 60.3 +/- 9.3), and 83 diabetic patients without PFP (41 females, mean age 59.5 +/- 9.9) were enrolled. The neurological examination, eye-blinking response, needle EMG and electrophysiological parameters of peripheral nerves were evaluated. The neuropathic pain, other positive and negative sensory symptoms were statistically more frequent in controls than the PFP group, while no difference was noted in total neuropathy score. Sural sensorial nerve action potential amplitudes were same in both groups, but median nerve amplitudes were significantly lower in the PFP group. It is suggested that PFP is not a part of multifocal neuropathy in diabetes mellitus. However, at least some parts of the nerve conduction studies were involved, focal neuropathies were more frequent while sensory neuropathies with small nerve fiber involvement were less frequent in diabetes patients with PFP.

Entities:  

Mesh:

Year:  2007        PMID: 17933462     DOI: 10.1016/j.neulet.2007.09.029

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Evaluation of Factors Associated With Favorable Outcomes in Adults With Bell Palsy.

Authors:  Myung Chul Yoo; Yunsoo Soh; Jinmann Chon; Jong Ha Lee; Junyang Jung; Sung Su Kim; Myung-Won You; Jae Yong Byun; Sang Hoon Kim; Seung Geun Yeo
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-03-01       Impact factor: 6.223

2.  Changes of Blink Reflex in Type 2 Diabetes Mellitus.

Authors:  Li Xiao; Kang Zou; Duoyan Zhou; Guilan Ouyang; Shuixiang Liu; Jun Luo
Journal:  J Diabetes Res       Date:  2021-03-12       Impact factor: 4.011

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.